CSIR approves project to develop ‘hmAbs’ that can neutralize SARS-CoV-2 in patients


HEALTH | MAY 09, 2020:

Council of Scientific and Industrial Reseach, CSIR is leading the fight against COVID-19 using multi-pronged approach and multiple models of engagement.

CSIR labs themselves are developing technologies and products and are working with industry and PSU partners for deployment while CSIR is also supporting new ideas and projects from other academic and industries through its flagship New Millennium Indian Technology Leadership Initiative, NMITLI programme.

Given the importance of deploying multiple strategies against COVID-19, CSIR through NMITLI programme has approved a project towards development of human monoclonal antibodies (hmAbs) that can neutralize